Sintx Technologies, Inc. (LON:0A8S)

London flag London · Delayed Price · Currency is GBP · Price in USD
2.710
-0.120 (-4.24%)
At close: Feb 12, 2026
Market Cap8.24M +145.5%
Revenue (ttm)944.80K -60.9%
Net Income-12.32M
EPS-5.74
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume25
Average Volume431
Open2.900
Previous Close2.830
Day's Range2.710 - 2.900
52-Week Range1.710 - 7.126
Beta0.65
RSI32.98
Earnings DateMar 20, 2026

About Sintx Technologies

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was in... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1996
Employees 20
Stock Exchange London Stock Exchange
Ticker Symbol 0A8S
Full Company Profile

Financial Performance

In 2024, Sintx Technologies's revenue was $2.89 million, an increase of 9.90% compared to the previous year's $2.63 million. Losses were -$11.02 million, 33.1% more than in 2023.

Financial numbers in USD Financial Statements

News

Insider Buying: Gregg Honigblum Acquires Additional Shares of SINTX Technologies Inc (SINT)

Insider Buying: Gregg Honigblum Acquires Additional Shares of SINTX Technologies Inc (SINT)

2 months ago - GuruFocus

Insider Buying: Gregg Honigblum Acquires 65,000 Shares of SINTX Technologies Inc (SINT)

Insider Buying: Gregg Honigblum Acquires 65,000 Shares of SINTX Technologies Inc (SINT)

2 months ago - GuruFocus

SINTX Technologies (SINT) Analyst Rating Update: Price Target Adjusted | SINT Stock News

SINTX Technologies (SINT) Analyst Rating Update: Price Target Adjusted | SINT Stock News

2 months ago - GuruFocus

SINTX (SINT) Partners with Evonik to Enhance Implant Manufacturing

SINTX (SINT) Partners with Evonik to Enhance Implant Manufacturing

2 months ago - GuruFocus

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

Milestone enables immediate production of SiN/PEEK custom devices SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advance...

2 months ago - GlobeNewsWire

SINTX (SINT) Reveals Decline in Q3 Revenue Amid Strategic Shift

SINTX (SINT) Reveals Decline in Q3 Revenue Amid Strategic Shift

3 months ago - GuruFocus

Insider Buying: Gregg Honigblum Acquires 10,000 Shares of SINTX Technologies Inc (SINT)

Insider Buying: Gregg Honigblum Acquires 10,000 Shares of SINTX Technologies Inc (SINT)

3 months ago - GuruFocus

SINTX Technologies (SINT) Introduces OsseoSculpt to Enhance Bone Healing

SINTX Technologies (SINT) Introduces OsseoSculpt to Enhance Bone Healing

3 months ago - GuruFocus

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

Clinical evaluation of the product by design surgeons completed, driving early commercial momentum SALT LAKE CITY, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SIN...

3 months ago - GlobeNewsWire

Insider Buying: Eric Olson Acquires Additional Shares of SINTX Technologies Inc (SINT)

Insider Buying: Eric Olson Acquires Additional Shares of SINTX Technologies Inc (SINT)

4 months ago - GuruFocus

SINTX Technologies (SINT) Gains FDA Clearance for New Surgical System

SINTX Technologies (SINT) Gains FDA Clearance for New Surgical System

4 months ago - GuruFocus

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

FDA cleared and U.S. manufactured implant system positions SINTX to enter billion-dollar U.S. market SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“S...

4 months ago - GlobeNewsWire

What Makes SINTX TECHNOLOGIES, INC. (SINT) a Strong Momentum Stock: Buy Now?

Does SINTX TECHNOLOGIES, INC. (SINT) have what it takes to be a top stock pick for momentum investors? Let's find out.

4 months ago - Nasdaq

SINTX Technologies (SINT) Secures Patent for Antipathogenic Fabric Technology

SINTX Technologies (SINT) Secures Patent for Antipathogenic Fabric Technology

4 months ago - GuruFocus

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

New method patent expands SINTX's infection-prevention IP portfolio in $30 Billion Total Addressable Market U.S. Patent Notice of Allowance reinforces competitive advantage and enables broader licensi...

4 months ago - GlobeNewsWire

SINTX Technologies (SINT) Secures $3.8 Million Through Warrant Exercise

SINTX Technologies (SINT) Secures $3.8 Million Through Warrant Exercise

5 months ago - GuruFocus

SINTX Technologies Announces Successful Exercise of Warrants for $3. ...

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds | SINT Stock News

5 months ago - GuruFocus

SINTX Technologies (SINT) Secures Key Patent for Antipathogenic Materials

SINTX Technologies (SINT) Secures Key Patent for Antipathogenic Materials

5 months ago - GuruFocus

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic ...

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent | SINT Stock News

5 months ago - GuruFocus

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

SALT LAKE CITY, Utah, Sept. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics innovator specializing in biomedical applications of s...

5 months ago - GlobeNewsWire

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

Significant Development in the Estimated $30 Billion Global Infection-Prevention Market SALT LAKE CITY, Utah, Sept. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the...

5 months ago - GlobeNewsWire

SINTX Technologies Publishes Landmark Study Demonstrating Broad-Spectrum Antiviral Activity of ...

SINTX Technologies Publishes Landmark Study Demonstrating Broad-Spectrum Antiviral Activity of Silicon Nitride | SINT Stock News

5 months ago - GuruFocus